Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BALLAD BELGIUM: A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

NCT04257461 is registered in ClinicalTrials.gov with Belgian Group of Digestive Oncology as lead sponsor.

NCT NCT04257461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04257461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BALLAD BELGIUM: A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
Lead sponsor
Belgian Group of Digestive Oncology
Phase
Phase 3
Overall status
Unknown status
Start date
February 20, 2020
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

small bowel adenocarcinoma